Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Dura Pharmaceuticals

Executive Summary

Dura Pharmaceuticals: Adds mail-order capacity as San Diego-based respiratory products firm signs definitive agreement to acquire Denver-based Health Script and its affiliates, which dispense respiratory products via mail-service. Health Scripts, according to Dura, had 1994 revenues of $8 mil. and provides mail-service prescription products, primarily nebulized solutions, to approximately 20,000 patients. Dura is purchasing the company through an undisclosed combination of cash and warrants. Health Script will remain in Denver and its two principals, President and founder Curtis Telley and VP-Sales Thomas Erlandson, are staying on board...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS025914

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel